Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice

Gastroenterology

Volumn 144, Issue 4, 2013, Pages

  Cao, Zongxian ^a   Mulvihill, Melinda M ^b   Mukhopadhyay, Partha ^a   Xu, Huan ^a   Erdélyi, Katalin ^a   Hao, Enkui ^a,c   Holovac, Eileen ^a   Haskó, György ^d   Cravatt, Benjamin F ^e   Nomura, Daniel K ^b   Pacher, Pál ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Eicosanoid Production; Endocannabinoid Signaling; Mouse Model; Surgery

Indexed keywords

ACYLGLYCEROL LIPASE; BIOLOGICAL MARKER; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CARBON TETRACHLORIDE; ENDOCANNABINOID; ESTERASE INHIBITOR; FATTY ACID AMIDASE; GALACTOSAMINE; ICOSANOID; JZL 184; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL CULTURE; CELL DEATH; ENZYME ACTIVITY; HEPATITIS; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER PROTECTION; MALE; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84875243228     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.12.028     Document Type: Article

References (35)

1. P. Pacher, G. Hasko Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning Br J Pharmacol 153 2008 252 262
2. K.B. Walsh, A.H. Toledo, F.A. Rivera-Chavez Inflammatory mediators of liver ischemia-reperfusion injury Exp Clin Transplant 7 2009 78 93
3. B. Horvath, L. Magid, P. Mukhopadhyay A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury Br J Pharmacol 165 2012 2462 2478
4. M. Kobayashi, I. Takeyoshi, M. Kurabayashi The effects of a cyclooxygenase-2 inhibitor, FK3311, on total hepatic ischemia-reperfusion injury of the rat Hepatogastroenterology 54 2007 522 526
5. S. Batkai, D. Osei-Hyiaman, H. Pan Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury FASEB J 21 2007 1788 1800
6. T. Hamada, S. Tsuchihashi, A. Avanesyan Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury J Immunol 180 2008 1843 1853
7. Y. Yokoyama, Y. Nimura, M. Nagino Role of thromboxane in producing hepatic injury during hepatic stress Arch Surg 140 2005 801 807
8. P. Pacher, R. Mechoulam Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50 2011 193 211
9. P. Caraceni, A.M. Pertosa, F. Giannone Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia Gut 58 2009 1135 1143
10. W.I. Jeong, D. Osei-Hyiaman, O. Park Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver Cell Metab 7 2008 227 235
11. F. Teixeira-Clerc, B. Julien, P. Grenard CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis Nat Med 12 2006 671 676
12. G. Kunos, J. Tam The case for peripheral CB(1) receptor blockade in the treatment of visceral obesity and its cardiometabolic complications Br J Pharmacol 163 2011 1423 1431
13. J. Tam, J. Liu, B. Mukhopadhyay Endocannabinoids in liver disease Hepatology 53 2011 346 355
14. D.K. Nomura, B.E. Morrison, J.L. Blankman Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation Science 334 2011 809 813
15. J.E. Schlosburg, J.L. Blankman, J.Z. Long Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat Neurosci 13 2010 1113 1119
16. S. Batkai, P. Mukhopadhyay, B. Horvath Delta8-tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors Br J Pharmacol 165 2012 2450 2461
17. Z. Cao, Y. Yuan, G. Jeyabalan Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor Am J Physiol Gastrointest Liver Physiol 297 2009 G249 G258
18. Z. Cao, R. Dhupar, C. Cai A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide J Immunol 185 2010 2536 2543
19. W. Liu, Y. Hou, H. Chen Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies Proteomics 11 2011 3556 3564
20. J.Z. Long, W. Li, L. Booker Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat Chem Biol 5 2009 37 44
21. C.K. Begay, A.J. Gandolfi Late administration of COX-2 inhibitors minimize hepatic necrosis in chloroform induced liver injury Toxicology 185 2003 79 87
22. C. Han, G. Li, K. Lim Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure J Immunol 181 2008 8027 8035
23. A. Louvet, F. Teixeira-Clerc, M.N. Chobert Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice Hepatology 54 2011 1217 1226
24. C.A. Rouzer, L.J. Marnett Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways Chem Rev 111 2011 5899 5921
25. E.Z. Dajani, K. Islam Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man J Physiol Pharmacol 59 Suppl 2 2008 117 133
26. S.G. Kinsey, D.K. Nomura, S.T. O'Neal Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice J Pharmacol Exp Ther 338 2011 795 802
27. P.K. Chanda, Y. Gao, L. Mark Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system Mol Pharmacol 78 2010 996 1003
28. B. Julien, P. Grenard, F. Teixeira-Clerc Antifibrogenic role of the cannabinoid receptor CB2 in the liver Gastroenterology 128 2005 742 755
29. H.K. Eltzschig, T. Eckle Ischemia and reperfusion - from mechanism to translation Nat Med 17 2011 1391 1401
30. A. Maheshwari, L. Badgujar, B. Phukan Protective effect of etoricoxib against middle cerebral artery occlusion induced transient focal cerebral ischemia in rats Eur J Pharmacol 667 2011 230 237
31. J.G. Zarruk, D. Fernandez-Lopez, I. Garcia-Yebenes Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection Stroke 43 2012 211 219
32. N. Defer, J. Wan, R. Souktani The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy FASEB J 23 2009 2120 2130
33. R.F. Tuma, S. Steffens Targeting the endocannabiniod system to limit myocardial and cerebral ischemic and reperfusion injury Curr Pharm Biotechnol 13 2012 46 58
34. F. Montecucco, S. Lenglet, V. Braunersreuther CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion J Mol Cell Cardiol 46 2009 612 620
35. D.K. Nomura, B.E. Morrison, J.L. Blankman Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation Science 334 2011 809 813